Information  X 
Enter a valid email address

Primary Health Props (PHP)


Wednesday 08 December, 2021

Primary Health Props

Director/PDMR Shareholding

RNS Number : 0262V
Primary Health Properties PLC
08 December 2021


Primary Health Properties PLC


Director shareholding


The Company has been advised that the following information relating to the transaction below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation



Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")



Anita Hyman



Reason for the notification



PCA, being the wife of Harry Hyman, CEO



Initial notification/ amendment

Initial notification



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



Name of Entity


Primary Health Properties PLC


Legal Entity Identifier




Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted


Description of the financial instrument

Ordinary shares of 12.5p



Nature of the transaction

Acquisition in monthly share plan



Price(s) and volume(s)






Aggregated information

Aggregated volume price


Single transaction



Date of transaction

6 December 2021



Place of transaction

London Stock Exchange (xlon)




For further information:

Primary Health Properties PLC

Paul Wright, Company Secretary

+44(0) 20 7451 7050

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t